Seroprevalence of anti-HAV among patients with chronic viral liver disease

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 2

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

428

HTML

4015

Figures (1-2)

217

Tables (1-4)

199

Sum=4859

Jan 14, 2011 (publication date) through Nov 4, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Jan 14, 2011; 17(2): 236-241
Published online Jan 14, 2011. doi: 10.3748/wjg.v17.i2.236

Table 2 Prevalence of IgG anti-hepatitis A virus in patients with hepatitis B virus vs those with hepatitis C virus infection n (%)

HBV: Hepatitis B virus; HCV: Hepatitis C virus; HAV: Hepatitis A virus.

Citation: Cho HC, Paik SW, Kim YJ, Choi MS, Lee JH, Koh KC, Yoo BC, Son HJ, Kim SW. Seroprevalence of anti-HAV among patients with chronic viral liver disease. World J Gastroenterol 2011; 17(2): 236-241
URL: https://www.wjgnet.com/1007-9327/full/v17/i2/236.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i2.236